Global Keloid Treatment Market By Treatment Type (Corticosteroid injections, Compression Therapy, Topical Products, Keloid surgery, Laser skin resurfacing, Cryotherapy and Others), By End-User (Hospitals, Dermatology & Aesthetic Clinics and Homecare), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: Jan 2026
Report ID: 176115
Number of Pages: 397
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
  - 1.8. Industry Voices
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Keloid Treatment Market Trends
  - 2.3. Technology Landscape
  - 2.4. Regulatory Framework
  - 2.5. Sustainability and ESG (Environmental, Social, Governance)
  - 2.6. Opportunity Map Analysis
  - 2.7. Opportunity Orbits
  - 2.8. PESTLE Analysis
  - 2.9. PORTER’S Five Force Analysis
  - 2.10. Drivers & Restraints Impact Analysis
  - 2.11. Value Chain Analysis
    
    2.11.1. List of Raw Materials Suppliers
    
    2.11.2. List of Keloid Treatment Manufacturers
    
    2.11.3. List of Dealer/Distributors
  - 2.12. Regional Market Share and BPS Analysis
  - 2.13. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Keloid Treatment Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 3.3. Global Keloid Treatment Market Attractiveness Analysis, By Treatment Type
    
    3.3.1. Corticosteroid Injections
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Compression Therapy
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Topical Products
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
    
    3.3.4. Keloid Surgery
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
    
    3.3.5. Laser Skin Resurfacing
    
    3.3.5.1. Insights
    
    3.3.5.2. Key Takeaways
    
    3.3.6. Cryotherapy
    
    3.3.6.1. Insights
    
    3.3.6.2. Key Takeaways
    
    3.3.7. Others
    
    3.3.7.1. Insights
    
    3.3.7.2. Key Takeaways
  - 3.4. Global Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  - 3.5. Global Keloid Treatment Market Attractiveness Analysis, By End-User
    
    3.5.1. Hospitals
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Dermatology & Aesthetic Clinics
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Homecare
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
- 4. Global Keloid Treatment Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Keloid Treatment Market Attractiveness Analysis, By Region
- 5. North America Keloid Treatment Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 5.3. North America Keloid Treatment Market Attractiveness Analysis, By Treatment Type
  - 5.4. North America Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  - 5.5. North America Keloid Treatment Market Attractiveness Analysis, By End-User
  - 5.6. North America Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.7. North America Keloid Treatment Market Attractiveness Analysis, By Country
    
    5.7.1. The US
    
    5.7.2. Canada
- 6. Europe Keloid Treatment Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 6.3. Europe Keloid Treatment Market Attractiveness Analysis, By Treatment Type
  - 6.4. Europe Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  - 6.5. Europe Keloid Treatment Market Attractiveness Analysis, By End-User
  - 6.6. Europe Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.7. Europe Keloid Treatment Market Attractiveness Analysis, By Country
    
    6.7.1. Germany
    
    6.7.2. The UK
    
    6.7.3. France
    
    6.7.4. Spain
    
    6.7.5. Italy
    
    6.7.6. Russia
    
    6.7.7. Netherland
    
    6.7.8. Rest of Europe
- 7. Asia Pacific Keloid Treatment Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 7.3. Asia Pacific Keloid Treatment Market Attractiveness Analysis, By Treatment Type
  - 7.4. Asia Pacific Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  - 7.5. Asia Pacific Keloid Treatment Market Attractiveness Analysis, By End-User
  - 7.6. Asia Pacific Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.7. Asia Pacific Keloid Treatment Market Attractiveness Analysis, By Country
    
    7.7.1. China
    
    7.7.2. Japan
    
    7.7.3. South Korea
    
    7.7.4. India
    
    7.7.5. Australia
    
    7.7.6. New Zealand
    
    7.7.7. Singapore
    
    7.7.8. Thailand
    
    7.7.9. Vietnam
    
    7.7.10. Rest of Asia Pacific
- 8. Latin America Keloid Treatment Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 8.3. Latin America Keloid Treatment Market Attractiveness Analysis, By Treatment Type
  - 8.4. Latin America Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  - 8.5. Latin America Keloid Treatment Market Attractiveness Analysis, By End-User
  - 8.6. Latin America Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.7. Latin America Keloid Treatment Market Attractiveness Analysis, By Country
    
    8.7.1. Brazil
    
    8.7.2. Mexico
    
    8.7.3. Rest of Latin America
- 9. Middle East & Africa Keloid Treatment Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 9.3. Middle East & Africa Keloid Treatment Market Attractiveness Analysis, By Treatment Type
  - 9.4. Middle East & Africa Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  - 9.5. Middle East & Africa Keloid Treatment Market Attractiveness Analysis, By End-User
  - 9.6. Middle East & Africa Keloid Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.7. Middle East & Africa Keloid Treatment Market Attractiveness Analysis, By Country
    
    9.7.1. South Africa
    
    9.7.2. Saudi Arabia
    
    9.7.3. UAE
    
    9.7.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Novartis AG
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Pfizer Inc.
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. F. Hoffmann-La Roche Ltd
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Merck & Co.
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Bristol-Myers Squibb Company
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Mölnlycke Health Care AB
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Galderma S.A
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Sensus Healthcare
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Perrigo Company plc
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Alliance Pharma PLC
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. Cynosure Inc.
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
    
    10.7.12. Cutera Inc
    
    10.7.12.1. Company Details
    
    10.7.12.2. Business Overview
    
    10.7.12.3. Product Portfolio
    
    10.7.12.4. Financial Insights
    
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.12.6. SWOT Analysis
    
    10.7.12.7. Geographic Footprint
    
    10.7.13. ScarAway
    
    10.7.13.1. Company Details
    
    10.7.13.2. Business Overview
    
    10.7.13.3. Product Portfolio
    
    10.7.13.4. Financial Insights
    
    10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.13.6. SWOT Analysis
    
    10.7.13.7. Geographic Footprint
    
    10.7.14. Bio Med Sciences
    
    10.7.14.1. Company Details
    
    10.7.14.2. Business Overview
    
    10.7.14.3. Product Portfolio
    
    10.7.14.4. Financial Insights
    
    10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.14.6. SWOT Analysis
    
    10.7.14.7. Geographic Footprint
    
    10.7.15. Lumenis
    
    10.7.15.1. Company Details
    
    10.7.15.2. Business Overview
    
    10.7.15.3. Product Portfolio
    
    10.7.15.4. Financial Insights
    
    10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.15.6. SWOT Analysis
    
    10.7.15.7. Geographic Footprint
    
    10.7.16. Sonoma Pharmaceuticals
    
    10.7.16.1. Company Details
    
    10.7.16.2. Business Overview
    
    10.7.16.3. Product Portfolio
    
    10.7.16.4. Financial Insights
    
    10.7.16.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.16.6. SWOT Analysis
    
    10.7.16.7. Geographic Footprint
    
    10.7.17. Smith & Nephew PLC
    
    10.7.17.1. Company Details
    
    10.7.17.2. Business Overview
    
    10.7.17.3. Product Portfolio
    
    10.7.17.4. Financial Insights
    
    10.7.17.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.17.6. SWOT Analysis
    
    10.7.17.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 2. Global Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 3. Global Keloid Treatment Market Value (US$ Mn), By Region, 2020-2034
- Table 4. North America Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 5. North America Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 6. North America Keloid Treatment Market Value (US$ Mn), By Country, 2020-2034
- Table 7. The US Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 8. The US Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 9. Canada Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 10. Canada Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 11. Europe Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 12. Europe Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 13. Europe Keloid Treatment Market Value (US$ Mn), By Country, 2020-2034
- Table 14. Germany Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 15. Germany Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 16. The UK Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 17. The UK Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 18. France Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 19. France Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 20. Spain Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 21. Spain Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 22. Italy Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 23. Italy Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 24. Russia Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 25. Russia Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 26. Netherland Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 27. Netherland Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 28. Rest of Europe Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 29. Rest of Europe Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 30. Asia Pacific Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 31. Asia Pacific Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 32. Asia Pacific Keloid Treatment Market Value (US$ Mn), By Country, 2020-2034
- Table 33. China Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 34. China Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 35. India Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 36. India Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 37. Japan Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 38. Japan Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 39. South Korea Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 40. South Korea Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 41. Australia Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 42. Australia Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 43. New Zealand Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 44. New Zealand Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 45. Singapore Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 46. Singapore Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 47. Thailand Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 48. Thailand Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 49. Vietnam Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 50. Vietnam Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 51. Rest of Asia Pacific Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 52. Rest of Asia Pacific Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 53. Latin America Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 54. Latin America Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 55. Latin America Keloid Treatment Market Value (US$ Mn), By Country, 2020-2034
- Table 56. Brazil Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 57. Brazil Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 58. Mexico Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 59. Mexico Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 60. Rest of Latin America Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 61. Rest of Latin America Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 62. Middle East & Africa Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 63. Middle East & Africa Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 64. Middle East & Africa Keloid Treatment Market Value (US$ Mn), By Country, 2020-2034
- Table 65. South Africa Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 66. South Africa Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 67. Saudi Arabia Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 68. Saudi Arabia Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 69. UAE Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 70. UAE Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
- Table 71. Rest of Middle East & Africa Keloid Treatment Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 72. Rest of Middle East & Africa Keloid Treatment Market Value (US$ Mn), By End-User, 2020-2034
List of Figures
- Figure 1. Global Keloid Treatment Market Snapshot: Market Value (US$ Mn), 2020-2034
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Keloid Treatment Market
- Figure 5. Global Keloid Treatment Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 6. Global Keloid Treatment Market Attractiveness Analysis, By Treatment Type
- Figure 7. Global Keloid Treatment Market Analysis, By End-User, 2020, 2024 and 2034
- Figure 8. Global Keloid Treatment Market Attractiveness Analysis, By End-User
- Figure 9. Global Keloid Treatment Market Analysis, By Region, 2020, 2024 and 2034
- Figure 10. Global Keloid Treatment Market Attractiveness Analysis, By Region
- Figure 11. North America Keloid Treatment Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 12. North America Keloid Treatment Market Attractiveness Analysis, By Treatment Type
- Figure 13. North America Keloid Treatment Market (US$ Mn), by Corticosteroid Injections, 2020-2034
- Figure 14. North America Keloid Treatment Market (US$ Mn), by Compression Therapy, 2020-2034
- Figure 15. North America Keloid Treatment Market (US$ Mn), by Topical Products, 2020-2034
- Figure 16. North America Keloid Treatment Market (US$ Mn), by Keloid Surgery, 2020-2034
- Figure 17. North America Keloid Treatment Market (US$ Mn), by Laser Skin Resurfacing, 2020-2034
- Figure 18. North America Keloid Treatment Market (US$ Mn), by Cryotherapy, 2020-2034
- Figure 19. North America Keloid Treatment Market (US$ Mn), by Others, 2020-2034
- Figure 20. North America Keloid Treatment Market Analysis, By End-User, 2020, 2024 and 2034
- Figure 21. North America Keloid Treatment Market Attractiveness Analysis, By End-User
- Figure 22. North America Keloid Treatment Market (US$ Mn), by Hospitals, 2020-2034
- Figure 23. North America Keloid Treatment Market (US$ Mn), by Dermatology & Aesthetic Clinics, 2020-2034
- Figure 24. North America Keloid Treatment Market (US$ Mn), by Homecare, 2020-2034
- Figure 25. North America Keloid Treatment Market Analysis, By Country, 2020, 2024 and 2034
- Figure 26. North America Keloid Treatment Market Attractiveness Analysis, By Country
- Figure 27. Europe Keloid Treatment Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 28. Europe Keloid Treatment Market Attractiveness Analysis, By Treatment Type
- Figure 29. Europe Keloid Treatment Market (US$ Mn), by Corticosteroid Injections, 2020-2034
- Figure 30. Europe Keloid Treatment Market (US$ Mn), by Compression Therapy, 2020-2034
- Figure 31. Europe Keloid Treatment Market (US$ Mn), by Topical Products, 2020-2034
- Figure 32. Europe Keloid Treatment Market (US$ Mn), by Keloid Surgery, 2020-2034
- Figure 33. Europe Keloid Treatment Market (US$ Mn), by Laser Skin Resurfacing, 2020-2034
- Figure 34. Europe Keloid Treatment Market (US$ Mn), by Cryotherapy, 2020-2034
- Figure 35. Europe Keloid Treatment Market (US$ Mn), by Others, 2020-2034
- Figure 36. Europe Keloid Treatment Market Analysis, By End-User, 2020, 2024 and 2034
- Figure 37. Europe Keloid Treatment Market Attractiveness Analysis, By End-User
- Figure 38. Europe Keloid Treatment Market (US$ Mn), by Hospitals, 2020-2034
- Figure 39. Europe Keloid Treatment Market (US$ Mn), by Dermatology & Aesthetic Clinics, 2020-2034
- Figure 40. Europe Keloid Treatment Market (US$ Mn), by Homecare, 2020-2034
- Figure 41. Europe Keloid Treatment Market Analysis, By Country, 2020, 2024 and 2034
- Figure 42. Europe Keloid Treatment Market Attractiveness Analysis, By Country
- Figure 43. Asia Pacific Keloid Treatment Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 44. Asia Pacific Keloid Treatment Market Attractiveness Analysis, By Treatment Type
- Figure 45. Asia Pacific Keloid Treatment Market (US$ Mn), by Corticosteroid Injections, 2020-2034
- Figure 46. Asia Pacific Keloid Treatment Market (US$ Mn), by Compression Therapy, 2020-2034
- Figure 47. Asia Pacific Keloid Treatment Market (US$ Mn), by Topical Products, 2020-2034
- Figure 48. Asia Pacific Keloid Treatment Market (US$ Mn), by Keloid Surgery, 2020-2034
- Figure 49. Asia Pacific Keloid Treatment Market (US$ Mn), by Laser Skin Resurfacing, 2020-2034
- Figure 50. Asia Pacific Keloid Treatment Market (US$ Mn), by Cryotherapy, 2020-2034
- Figure 51. Asia Pacific Keloid Treatment Market (US$ Mn), by Others, 2020-2034
- Figure 52. Asia Pacific Keloid Treatment Market Analysis, By End-User, 2020, 2024 and 2034
- Figure 53. Asia Pacific Keloid Treatment Market Attractiveness Analysis, By End-User
- Figure 54. Asia Pacific Keloid Treatment Market (US$ Mn), by Hospitals, 2020-2034
- Figure 55. Asia Pacific Keloid Treatment Market (US$ Mn), by Dermatology & Aesthetic Clinics, 2020-2034
- Figure 56. Asia Pacific Keloid Treatment Market (US$ Mn), by Homecare, 2020-2034
- Figure 57. Asia Pacific Keloid Treatment Market Analysis, By Country, 2020, 2024 and 2034
- Figure 58. Asia Pacific Keloid Treatment Market Attractiveness Analysis, By Country
- Figure 59. Latin America Keloid Treatment Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 60. Latin America Keloid Treatment Market Attractiveness Analysis, By Treatment Type
- Figure 61. Latin America Keloid Treatment Market (US$ Mn), by Corticosteroid Injections, 2020-2034
- Figure 62. Latin America Keloid Treatment Market (US$ Mn), by Compression Therapy, 2020-2034
- Figure 63. Latin America Keloid Treatment Market (US$ Mn), by Topical Products, 2020-2034
- Figure 64. Latin America Keloid Treatment Market (US$ Mn), by Keloid Surgery, 2020-2034
- Figure 65. Latin America Keloid Treatment Market (US$ Mn), by Laser Skin Resurfacing, 2020-2034
- Figure 66. Latin America Keloid Treatment Market (US$ Mn), by Cryotherapy, 2020-2034
- Figure 67. Latin America Keloid Treatment Market (US$ Mn), by Others, 2020-2034
- Figure 68. Latin America Keloid Treatment Market Analysis, By End-User, 2020, 2024 and 2034
- Figure 69. Latin America Keloid Treatment Market Attractiveness Analysis, By End-User
- Figure 70. Latin America Keloid Treatment Market (US$ Mn), by Hospitals, 2020-2034
- Figure 71. Latin America Keloid Treatment Market (US$ Mn), by Dermatology & Aesthetic Clinics, 2020-2034
- Figure 72. Latin America Keloid Treatment Market (US$ Mn), by Homecare, 2020-2034
- Figure 73. Latin America Keloid Treatment Market Analysis, By Country, 2020, 2024 and 2034
- Figure 74. Latin America Keloid Treatment Market Attractiveness Analysis, By Country
- Figure 75. Middle East & Africa Keloid Treatment Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 76. Middle East & Africa Keloid Treatment Market Attractiveness Analysis, By Treatment Type
- Figure 77. Middle East & Africa Keloid Treatment Market (US$ Mn), by Corticosteroid Injections, 2020-2034
- Figure 78. Middle East & Africa Keloid Treatment Market (US$ Mn), by Compression Therapy, 2020-2034
- Figure 79. Middle East & Africa Keloid Treatment Market (US$ Mn), by Topical Products, 2020-2034
- Figure 80. Middle East & Africa Keloid Treatment Market (US$ Mn), by Keloid Surgery, 2020-2034
- Figure 81. Middle East & Africa Keloid Treatment Market (US$ Mn), by Laser Skin Resurfacing, 2020-2034
- Figure 82. Middle East & Africa Keloid Treatment Market (US$ Mn), by Cryotherapy, 2020-2034
- Figure 83. Middle East & Africa Keloid Treatment Market (US$ Mn), by Others, 2020-2034
- Figure 84. Middle East & Africa Keloid Treatment Market Analysis, By End-User, 2020, 2024 and 2034
- Figure 85. Middle East & Africa Keloid Treatment Market Attractiveness Analysis, By End-User
- Figure 86. Middle East & Africa Keloid Treatment Market (US$ Mn), by Hospitals, 2020-2034
- Figure 87. Middle East & Africa Keloid Treatment Market (US$ Mn), by Dermatology & Aesthetic Clinics, 2020-2034
- Figure 88. Middle East & Africa Keloid Treatment Market (US$ Mn), by Homecare, 2020-2034
- Figure 89. Middle East & Africa Keloid Treatment Market Analysis, By Country, 2020, 2024 and 2034
- Figure 90. Middle East & Africa Keloid Treatment Market Attractiveness Analysis, By Country
- Novartis AG
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Mölnlycke Health Care AB
- Galderma S.A.
- Sensus Healthcare
- Perrigo Company plc (ScarAway)
- Alliance Pharma PLC (Kelo-Cote)
- Cynosure Inc.
- Cutera Inc.
- Bio Med Sciences
- Lumenis
- Sonoma Pharmaceuticals
- Smith & Nephew PLC